These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 17619349

  • 21. JIKEI HEART Study--a morbi-mortality and remodeling study with valsartan in Japanese patients with hypertension and cardiovascular disease.
    Mochizuki S, Shimizu M, Taniguchi I, Kanae K, Yoshida S, Tajima N, Dahlöf B, JIKEI HEART Study Group.
    Cardiovasc Drugs Ther; 2004 Jul; 18(4):305-9. PubMed ID: 15367828
    [Abstract] [Full Text] [Related]

  • 22. [AT1 blocker or calcium antagonist in treatment of hypertension. What protects the heart better?].
    Einecke D.
    MMW Fortschr Med; 2004 Jun 24; 146(26):12. PubMed ID: 15529682
    [No Abstract] [Full Text] [Related]

  • 23. [Valsartan improves symptoms and quality of life in patients with chronic heart failure].
    Baumhäkel M, Müller U, Böhm M.
    MMW Fortschr Med; 2008 Apr 10; 150 Suppl 1():48-53. PubMed ID: 18540333
    [Abstract] [Full Text] [Related]

  • 24. Sartans for hypertension--implications of the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial.
    Cheung BM.
    Hong Kong Med J; 2004 Oct 10; 10(5):359. PubMed ID: 15479968
    [No Abstract] [Full Text] [Related]

  • 25. Angiotensin receptor blockers and heart failure: still CHARMing after VALIANT?
    Swedberg K, McMurray JJ.
    Eur Heart J; 2004 Mar 10; 25(5):357-8. PubMed ID: 15033244
    [No Abstract] [Full Text] [Related]

  • 26. [Valsartan improves symptoms and quality of life in patients with chronic heart failure].
    Baumhäkel M, Müller U.
    MMW Fortschr Med; 2008 Dec 04; 150(49-50):55. PubMed ID: 19133371
    [No Abstract] [Full Text] [Related]

  • 27. [Sartan as a new therapy option. When heart failure patients cannot tolerate an ACE inhibitor].
    MMW Fortschr Med; 2002 Oct 03; 144(40):49. PubMed ID: 12440300
    [No Abstract] [Full Text] [Related]

  • 28. [Preventing end-organ damage in hypertension. What is the significance of the VALUE Study for general practice?].
    Zidek W.
    MMW Fortschr Med; 2004 Jul 08; 146(27-28):41. PubMed ID: 15526662
    [No Abstract] [Full Text] [Related]

  • 29. Angiotensin II receptor antagonists for the treatment of heart failure: what is their place after ELITE-II and Val-HeFT?
    McMurray JJ.
    J Renin Angiotensin Aldosterone Syst; 2001 Jun 08; 2(2):89-92. PubMed ID: 11881104
    [No Abstract] [Full Text] [Related]

  • 30. [Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].
    Roger N, Popovic I, Madelenat P, Mahieu-Caputo D.
    Gynecol Obstet Fertil; 2007 Jun 08; 35(6):556-60. PubMed ID: 17544313
    [Abstract] [Full Text] [Related]

  • 31. Hope in Life and Value of blood pressure control.
    Ruilope LM, Segura J.
    J Hypertens; 2004 Dec 08; 22(12):2265-6. PubMed ID: 15614017
    [No Abstract] [Full Text] [Related]

  • 32. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C, Croce G, Desideri G.
    Adv Ther; 2008 Apr 08; 25(4):300-20. PubMed ID: 18449492
    [Abstract] [Full Text] [Related]

  • 33. Rationale for angiotensin II receptor blocker therapy in chronic heart failure.
    Cohn JN.
    J Renin Angiotensin Aldosterone Syst; 2000 Jun 08; 1(2 Suppl):S38-40. PubMed ID: 17199220
    [Abstract] [Full Text] [Related]

  • 34. [New effective dosage of valsartan. High dosage--effective against high blood pressure].
    MMW Fortschr Med; 2007 Nov 15; 149(46):52-3. PubMed ID: 18069195
    [No Abstract] [Full Text] [Related]

  • 35. VALUE: analysis of results.
    Kario K, Pickering T.
    Lancet; 2007 Nov 15; 364(9438):934; author reply 935. PubMed ID: 15364182
    [No Abstract] [Full Text] [Related]

  • 36. [AT1 receptor antagonists in treatment of hypertension].
    Franz IW.
    Fortschr Med; 1997 Jul 10; 115(19):38-40. PubMed ID: 9333581
    [No Abstract] [Full Text] [Related]

  • 37. [Despite drug treatment, ever second hypertensive patient with morning blood pressure too high].
    MMW Fortschr Med; 2004 Aug 19; 146(33-34):52. PubMed ID: 15526635
    [No Abstract] [Full Text] [Related]

  • 38. [VALUE study underscores the importance of reaching goal blood pressure values for minimization of cardiovascular risks].
    Praxis (Bern 1994); 2004 Oct 27; 93(44):1836. PubMed ID: 15559910
    [No Abstract] [Full Text] [Related]

  • 39. [Cardiologic and diabetologic aspects of therapy with angiotensin receptor blocking agents].
    Winkler G, Jermendy G, Matos L.
    Orv Hetil; 2003 Sep 21; 144(38):1861-7. PubMed ID: 14596024
    [Abstract] [Full Text] [Related]

  • 40. Aldosterone levels after angiotensin receptor blocker treatment.
    Folkeringa RJ, Pinto YM, Crijns HJ.
    Circulation; 2004 Apr 13; 109(14):e182; author reply e182. PubMed ID: 15078811
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.